CN1061863C - Medicine for external use for treatment of psoriasis - Google Patents

Medicine for external use for treatment of psoriasis Download PDF

Info

Publication number
CN1061863C
CN1061863C CN96108485A CN96108485A CN1061863C CN 1061863 C CN1061863 C CN 1061863C CN 96108485 A CN96108485 A CN 96108485A CN 96108485 A CN96108485 A CN 96108485A CN 1061863 C CN1061863 C CN 1061863C
Authority
CN
China
Prior art keywords
medicine
gram
external
radix aconiti
aconiti kusnezoffii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96108485A
Other languages
Chinese (zh)
Other versions
CN1169297A (en
Inventor
武占元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96108485A priority Critical patent/CN1061863C/en
Publication of CN1169297A publication Critical patent/CN1169297A/en
Application granted granted Critical
Publication of CN1061863C publication Critical patent/CN1061863C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to external-use medicine for treating psoriasis, which comprises salicylic acid, raw radix aconiti kusnezoffii and procaine which are mixed in a container, alcohol is added, the raw materials are soaked for more than 7 days, and then, the raw radix aconiti kusnezoffii is filtered so the external-use medicine is obtained. The external-use medicine realizes that traditional Chinese medicine and western medicine cooperate with each other and is applied to afflicted parts when used. The medicine has the advantages of good curative effect, low irritation and high cure rate.

Description

The psoriatic medicine for external use of a kind of treatment
The present invention relates to treat psoriatic medicine for external use.
In the prior art, treating psoriatic medicine for external use (especially strong concentration) has strong impulse, even causes allergic dermatitis, the patient is impatient at and is forced to drug withdrawal, though the preparation zest of weak concentration is little, curative effect is not obvious, and after the treatment easily repeatedly.
The purpose of this invention is to provide the higher psoriatic medicine for external use of the strong excessively treatment of zest that do not cause again of a kind of concentration.
Purpose of the present invention realizes by following measure, treats psoriatic medicine for external use and comprises following composition:
Salicylic acid 1-20 gram
Radix Aconiti Kusnezoffii 1-20 gram
Procaine 1-20 gram
After mixing, said medicine adds 70% ethanol to 100 milliliter.Soak more than 7 days, leach Radix Aconiti Kusnezoffii, be external medicinal liquid.
Also comprise Shrubalthea Bark 3-20 gram in the composition, Radix Rumicis Japonici restrains with 10-30.
This medicinal liquid is packed into, and dark bottles is interior to be sealed, and is placed on lucifuge, dark dry place preservation, and the time spent puts on the skin in the affected part and gets final product.
Salicylic acid in the above-mentioned composition has horny layer softening, mould fungus inhibition and itching relieving effect; its concentration has cutin during for 1-2% and facilitates effect; promptly promote epidermis to form; make abnormal keratinization (as parakeratosis) normalization; when being 1-3%, its content also has itching-relieving action; ointment when its content is 5-15% can make epidermis cell generation swelling in relatively moister environment soften and peel off; become the angleplied laminate remover; when treatment superficial part fungal infection was sick, the mycete that is killed i.e. peeling off and come off with epidermis.
Radix Aconiti Kusnezoffii has the dual function of antifungal and local anesthesia, procaine is an anesthetics, all medicines cooperate, not only suppressed to kill mycete but also supported and cut the intense stimulus that the acid of high concentration bigcatkin willow causes, thereby in constantly angleplied laminate was peeled off, the mycete that is killed broke away from and death gradually, use when not peeling always, for preventing recurrence, adhere to again afterwards can eradicating with 1-2 month.
Narrate below in conjunction with embodiment.
Embodiment: treat psoriatic medicine for external use and comprise following composition:
Salicylic acid 10 grams
Radix Aconiti Kusnezoffii 15 grams
Procaine 15 grams
Add 70% ethanol to 100 milliliter after said medicine is mixed, soak more than 7 days, leach Radix Aconiti Kusnezoffii, be external medicinal liquid.

Claims (2)

1, the psoriatic medicine for external use of a kind of treatment is characterized in that being made up of following composition:
Salicylic acid 1-20 gram
Radix Aconiti Kusnezoffii 1-20 gram
Procaine 1-20 gram
Add 70% ethanol to 100 milliliter after said medicine is mixed, soak more than 7 days, leach Radix Aconiti Kusnezoffii, be external medicinal liquid.
2, the psoriatic medicine for external use of a kind of treatment is characterized in that being made up of following Chinese medicinal ingredients
Salicylic acid 1-20 gram
Radix Aconiti Kusnezoffii 1-20 gram
Procaine 1-20 gram
Shrubalthea Bark 3-20 gram
Radix Rumicis Japonici restrains with 10-30
Add 70% ethanol to 100 milliliter after said medicine is mixed, soak more than 7 days, leach Radix Aconiti Kusnezoffii, be external medicinal liquid.
CN96108485A 1996-06-28 1996-06-28 Medicine for external use for treatment of psoriasis Expired - Fee Related CN1061863C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96108485A CN1061863C (en) 1996-06-28 1996-06-28 Medicine for external use for treatment of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96108485A CN1061863C (en) 1996-06-28 1996-06-28 Medicine for external use for treatment of psoriasis

Publications (2)

Publication Number Publication Date
CN1169297A CN1169297A (en) 1998-01-07
CN1061863C true CN1061863C (en) 2001-02-14

Family

ID=5119978

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96108485A Expired - Fee Related CN1061863C (en) 1996-06-28 1996-06-28 Medicine for external use for treatment of psoriasis

Country Status (1)

Country Link
CN (1) CN1061863C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108125967A (en) * 2017-12-25 2018-06-08 陕西佰傲再生医学有限公司 A kind of dressing and preparation method for being used to alleviate psoriasis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1104526A (en) * 1994-07-02 1995-07-05 左水臣 Kangsu lotion for burn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1104526A (en) * 1994-07-02 1995-07-05 左水臣 Kangsu lotion for burn

Also Published As

Publication number Publication date
CN1169297A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
US3943248A (en) Methods of treating burns using colophony containing preparations
US20070098671A1 (en) Composition and method of treatment for irritated skin
EP0621787A4 (en) Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed.
US7141252B2 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
CN1061863C (en) Medicine for external use for treatment of psoriasis
CN107595819B (en) A kind of Nano diamond modified liquid adhesive bandage and preparation method thereof
CN1839898A (en) Scar-free wet ointment for scald and burn and its preparation method
US11154583B2 (en) Composition and method of skin relief cream useful for eczema, psoriasis, lipoma, burn wounds, scars, keloids, shingles, dry skin disorders, and skin allergies
CN1864729A (en) A wound healing pure Chinese medicine
CN108853369B (en) Preparation method and application of natural plant antibacterial liquid PAMs hydrogel patch
US5616619A (en) Topical composition for burn relief and method of use
CN1221786A (en) Medicinal soap containing propolis
TWM610166U (en) Microcapsule structure
CN1131067C (en) Tinea pedis eliminating medicine
CN110063992A (en) Burn and scald medication and preparation method thereof
CN111184674A (en) Oral care agent for superficial wound care and application method thereof
CN115634251A (en) Preparation method of aloe gel externally applied medicine for wound
RU2256441C1 (en) Ointment for treatment of burn, suppurative and infected wound of different etiology and method for treatment of burn, suppurative and infected wound
CN111407708B (en) Gel skin care patch containing sodium hyaluronate
CN1105561C (en) Medicinal prepns. for treating underarm odour and beriberi
CN106038825B (en) Ointment for promoting wound healing and preparation method thereof
AU687840B2 (en) Topical composition for burn relief and method of use
CN111481615A (en) Taxus chinensis liquid medicine for treating burns and scalds and recovering scars
Yensuari et al. Effectiveness Of Red Betel Leaf Ointment (Piper Crocatum, Ruiz & Pav) On Slash Wounds In White Mice
CN117797086A (en) Anti-inflammatory acne-removing medicinal gel and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee